Table 4.
Variable | OR | p-value |
---|---|---|
Age | 1.11 (0.94 – 1.01) | 0.23 |
BMI | 0.90 (0.74–1.10) | 0.31 |
Axillary Dissection vs SLNBx | 1.79 (0.27 – 11.86) | 0.55 |
Laterality - Right vs Left | 0.20 (0.02 – 1.91) | 0.16 |
Histologic Grade (Ref = Grade 1) | ||
Grade 2 | 2.44 (0.23 – 26.29) | 0.41 |
Grade 3 | 8.66 (0.58–130.07) | 0.56 |
Hormonal Therapy (Ref = None) | ||
Tamoxifen | 3.00 (0.18 – 50.79) | 0.26 |
AI | 1.00 (0.15 – 6.91) | 0.91 |
Bra Cup Size ≥ D | 2.43 (0.38 – 15.27) | 0.34 |
Tumor Size (cm) | 1.52 (0.46 – 5.00) | 0.49 |
PTV D95% | 1.20 (0.43 – 3.39) | 0.73 |
PTV Max Dose | 1.06 (0.67 – 1.68) | 0.80 |
Lung V10Gy | 1.95 (0.72 – 5.25) | 0.19 |
Breast V20Gy | 1.22 (1.03 – 1.44) | 0.02 |
Breast V40Gy | 1.26 (1.03 – 1.54) | 0.03 |
Breast V20Gy ≥ 30.48 % | 15.00 (1.52 – 148.31) | 0.02 |
Breast V40Gy ≥ 19.48 % | 15.00 (1.52 – 148.31) | 0.02 |
Note: BMI = body-mass index; SLNBx = sentinel lymph node biopsy Ref = reference; AI = aromatase inhibitor; PTV = planning target volume; Gy = Gray.
Bold denotes statistical significance.